ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 65 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $28,000 | -24.3% | 4,773 | -1.0% | 0.00% | – |
| Q3 2019 | $37,000 | +37.0% | 4,823 | +148.5% | 0.00% | – |
| Q2 2019 | $27,000 | +350.0% | 1,941 | +88.3% | 0.00% | – |
| Q1 2019 | $6,000 | +100.0% | 1,031 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -62.5% | 1,031 | 0.0% | 0.00% | – |
| Q3 2018 | $8,000 | -20.0% | 1,031 | 0.0% | 0.00% | – |
| Q2 2018 | $10,000 | +11.1% | 1,031 | 0.0% | 0.00% | – |
| Q1 2018 | $9,000 | -30.8% | 1,031 | 0.0% | 0.00% | – |
| Q4 2017 | $13,000 | +116.7% | 1,031 | +41.0% | 0.00% | – |
| Q3 2017 | $6,000 | -57.1% | 731 | -9.9% | 0.00% | – |
| Q2 2017 | $14,000 | -44.0% | 811 | -34.1% | 0.00% | -100.0% |
| Q1 2017 | $25,000 | +127.3% | 1,231 | +68.4% | 0.00% | – |
| Q4 2016 | $11,000 | – | 731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 1,510,872 | $800,762 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 122,892 | $65,133 | 0.01% |
| Bernardo Wealth Planning LLC | 38,578 | $20,446 | 0.01% |
| Key FInancial Inc | 7,500 | $5,490 | 0.00% |
| Penserra Capital Management LLC | 215,722 | $114 | 0.00% |
| King Wealth Management Group | 16,000 | $8 | 0.00% |
| Newbridge Financial Services Group, Inc. | 6,075 | $3,220 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,900 | $61,427 | 0.00% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $26,341 | 0.00% |
| Founders Capital Management | 2,000 | $1 | 0.00% |